Compare McCormick & Company, Incorporated (MKC) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McCormick & Company, Incorporated vs Moderna, Inc. — how do they compare? McCormick & Company, Incorporated trades at $52.73 (market cap $14.22B), while Moderna, Inc. trades at $60.53 (market cap $24.18B). The key difference: Moderna, Inc. is the larger of the two by market cap, and McCormick & Company, Incorporated pays a 3.63% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MKC | MRNA | |
|---|---|---|
Market Cap | $14.22B | $24.18B |
Sector | Consumer Staples | Health |
52-Week High | $72.26 | $81.80 |
52-Week Low | $45.60 | $22.36 |
Enterprise Value | $18.82B | $20.33B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McCormick & Company, Incorporated
In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
